申请人:Merck & Co., Inc.
公开号:EP0341961A2
公开(公告)日:1989-11-15
The invention relates to novel polymalonic acids which act as bone-affinity agents. Compounds of the formula
have a high affinity for bone and are useful in the treatment and prevention of diseases involving bone resorption, particularly osteoporosis, Paget's disease, and malignant hypercalcemia, by delivering a bone resorption or formation active-drug directly to the bone target site.
本发明涉及可作为骨亲和剂的新型聚丙二酸。式中化合物
对骨具有高亲和力,通过将骨吸收或骨形成活性药物直接输送到骨靶部位,可用于治疗和预防涉及骨吸收的疾病,特别是骨质疏松症、Paget 病和恶性高钙血症。